4RX9 | pdb_00004rx9

SYK Catalytic Domain Complexed with a Potent Pyrimidine Inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.75 Å
  • R-Value Free: 
    0.197 (Depositor), 0.190 (DCC) 
  • R-Value Work: 
    0.174 (Depositor), 0.171 (DCC) 
  • R-Value Observed: 
    0.175 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4RX9

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery and profiling of a selective and efficacious syk inhibitor.

Thoma, G.Smith, A.B.van Eis, M.J.Vangrevelinghe, E.Blanz, J.Aichholz, R.Littlewood-Evans, A.Lee, C.C.Liu, H.Zerwes, H.G.

(2015) J Med Chem 58: 1950-1963

  • DOI: https://doi.org/10.1021/jm5018863
  • Primary Citation Related Structures: 
    4RX7, 4RX8, 4RX9

  • PubMed Abstract: 

    We describe the discovery of selective and potent Syk inhibitor 11, which exhibited favorable PK profiles in rat and dog and was found to be active in a collagen-induced arthritis model in rats. Compound 11 was selected for further profiling, but, unfortunately, in GLP toxicological studies it showed liver findings in rat and dog. Nevertheless, 11 could become a valuable tool compound to investigate the rich biology of Syk in vitro and in vivo.


  • Organizational Affiliation
    • Global Discovery Chemistry, ‡Analytical Sciences & Imaging, §Autoimmunity, Transplantation and Inflammation Research, Novartis Institutes for Biomedical Research , 4056 Basel, Switzerland.

Macromolecule Content 

  • Total Structure Weight: 34.29 kDa 
  • Atom Count: 2,416 
  • Modeled Residue Count: 268 
  • Deposited Residue Count: 290 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Tyrosine-protein kinase SYK290Homo sapiensMutation(s): 0 
Gene Names: SYK
EC: 2.7.10.2
UniProt & NIH Common Fund Data Resources
Find proteins for P43405 (Homo sapiens)
Explore P43405 
Go to UniProtKB:  P43405
PHAROS:  P43405
GTEx:  ENSG00000165025 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP43405
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
3YT

Query on 3YT



Download:Ideal Coordinates CCD File
C [auth A]2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl)phenyl]amino}pyrimidine-5-carboxamide
C19 H23 N9 O
TXGKRVFSSHPBAJ-JKSUJKDBSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
B [auth A]GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
3YT BindingDB:  4RX9 IC50: min: 1, max: 1.00e+4 (nM) from 15 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.75 Å
  • R-Value Free:  0.197 (Depositor), 0.190 (DCC) 
  • R-Value Work:  0.174 (Depositor), 0.171 (DCC) 
  • R-Value Observed: 0.175 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 39.978α = 90
b = 85.126β = 90
c = 89.776γ = 90
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
BUSTER-TNTrefinement
PDB_EXTRACTdata extraction
HKL-2000data reduction
HKL-2000data scaling
BUSTERrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2015-03-18 
  • Deposition Author(s): Lee, C.C.

Revision History  (Full details and data files)

  • Version 1.0: 2015-03-18
    Type: Initial release
  • Version 1.1: 2017-11-22
    Changes: Refinement description
  • Version 1.2: 2024-02-28
    Changes: Data collection, Database references, Derived calculations